NeuroTheryX Partners with Cyclica to Launch NineteenGale Therapeutics to Advance First-In-Class Cannabinoid-Inspired Drugs for Neuropsychiatric Disorders
TORONTO–(BUSINESS WIRE)– #artificialintelligence–NeuroTheryX Partners with Cyclica to Launch NineteenGale Therapeutics to Advance Cannabinoid-Inspired Drugs for Neuropsychiatric Disorders.